Navigation Links
Health Diagnostic Laboratory, Inc. (HDL, Inc.) Brings Advanced Testing to Capitol Hill, Discusses Health Care Cost Savings and Quality Improvement Potential

RICHMOND, Va., July 5, 2012 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. (HDL, Inc.) is bringing its innovative approach to identifying and managing risk for chronic disease to the Nation's Capital for the inaugural Population Health Innovations Showcase, Wednesday, July 11, 2012, on Capitol Hill. Care Continuum Alliance (CCA), the leading voice in population health, is hosting the Showcase to provide a forum for population health and chronic disease management innovators to share expertise, technology, and strategies with lawmakers, regulatory and government officials, and others who work on expanding access to wellness, prevention and care management. WHAT: Health Diagnostic Laboratory, Inc. presents interactive display of advanced biomarker testing allowing for sophisticated health risk stratification, patient engagement and positive population health outcomes. WHEN: Wednesday, July 11, 201211 am – 2 pm Networking Lunch and Interactive Displays 5 – 7 pm Evening Reception and Interactive Displays

 WHERE:Rayburn House Office Building, Rayburn Foyer

 WHO:Health Diagnostic Laboratory, Inc. Anna McKean, Executive VP of Strategic Initiatives Mark Herzog, Senior Vice President of Corporate & Governmental Affairs

 WHY:As a CCA member, Health Diagnostic Laboratory, Inc., will display innovative technologies such as advanced biomarker testing and personal health coaching that can cut costs and improve health care delivery, showcasing the Alliance's commitment to accountable and value-driven care. Members of Congress, their staff and State and Federal government officials will see the impact of these high-tech tools in the lives of their constituents.


Audience members will be able to ask questions, review sample test reports, and understand their benefits for population health management, as the country faces the challenges of deficit reduction, escalating health care costs and rising rates of chronic disease."Health Diagnostic Laboratory looks forward to our participation in the Population Health Innovations Showcase and to educating leaders in government about life saving technologies that provide positive outcomes on the health care system," said Anna McKean, Executive VP of Strategic Initiatives at HDL, Inc.

"Currently, the incidence of chronic disease continues to accelerate despite widespread laboratory testing. Health Diagnostic Laboratory was founded on the premise that many widely used laboratory tests do not adequately identify the risk for specific chronic diseases, and therefore limit the opportunity for prevention," said Mckean.

The Centers for Disease Control reports that 75% of overall medical costs are driven by preventable chronic conditions like cardiovascular disease (CVD) and diabetes. Health risk, however, are not identified until after disease reaches a chronic state. Health Diagnostic Laboratory, Inc. will attend the inaugural Population Health Innovations Showcase with a mission to help change the paradigm and to identify disease risk earlier so that the conditions can be treated and even reversed. 

HDL, Inc., a fully CAP/CLIA accredited clinical laboratory, is surpassing the traditional lipid blood test by offering an innovative biomarker panel of laboratory blood tests. By testing for inflammation, oxidative and myocardial stress, metabolic function, along with lipoprotein particles and pharmacogenetic markers, medical professionals can tailor the most effective treatment based on an expanded, comprehensive patient profile.  The result -- earlier detection of risk factors, more advanced evidence-based treatments, and fewer patients progressing to overt cardiovascular disease and diabetes. 

The HDL, Inc. approach emphasizes prevention of disease by utilizing evidence-based practice guidelines and patient empowerment strategies.  Evidence-based and actionable biomarkers in blood testing are available and affordable to practicing clinicians, patients, as well as employer groups. These innovative tests coupled with patient-engagement strategies hold enormous promise for reversing the rising global trends in cardiovascular disease and diabetes.
This approach to healthcare results in improved clinical knowledge and improved quality in patient care, which ultimately creates significant reduction in healthcare costs.

For more information Population Health Innovations Showcase

About Health Diagnostic Laboratory, Inc. Health Diagnostic Laboratory, Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients. As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Health Coaches at no additional cost, improving compliance and enhancing satisfaction. For more information about HDL, please visit

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
2. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
3. Uroplasty To Present At The JMP Securities Healthcare Conference
4. Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
5. PatientPay from Zepherella Now Offers Real-time Pricing, Automatic Payment Reconciliation for Healthcare Providers and Patients
6. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
7. EvergreenHealth Encourages Community to Use Free Microsoft Service to Store Personal Health Information for Emergencies
8. ViroPharma To Participate In The JMP Securities Healthcare Conference
9. Tara Dall, MD Joins Health Diagnostic Laboratory (HDL, Inc.) as Chief Medical Officer
10. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
11. MedVantx Names New VP Employer Solutions and Workplace Health
Post Your Comments:
(Date:11/24/2015)... N.Y. , Nov. 24, 2015 Avery ... System, is pleased to announce the appointment of ... Dr. ... pediatric cardiology at Children,s Hospital, Uppsala University, Uppsala and ... From 1984-1986, he was a fellow at the Cardiovascular ...
(Date:11/24/2015)... India , November 24, 2015 ... . --> adds Latest Guidebook ... report of 217 pages published in November 2015 ... its online business intelligence library at ... one of the fastest growing global economies with ...
(Date:11/24/2015)... , Nov. 24, 2015  Ascendant Solutions, Inc. (Pink Sheets: ... its Board of Directors has declared a special 1 percent ... dividend is payable December 14, 2015, to shareholders of record ... form of additional shares of common stock. ... Board is a strong endorsement of our confidence in Ascendant,s ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion Bootie , the ... celebration of the early holiday shopping season. Starting Wednesday November 25th, Bunion Booties ... Black Friday promotional pricing is in addition to any automatic discounts applied when ...
(Date:11/24/2015)... ... , ... Dr. Todd S. Afferica, a noted general dentist in Norcross, ... Dr. Afferica now uses the BIOLASE WaterLase iPlus 2.0™ in many of his dental ... other traditional cutting tools, such as the scalpel and high-speed drill, which can both ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Charitable giving ... charitable donations are made in the last five weeks of the year totalling over ... created in 2012 to connect the nation’s charities with those individuals who want to ...
(Date:11/24/2015)... ... November 25, 2015 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced that Dr. Christine Milligan, ... East Asia Conference, to be held at the InterContinental Seoul COEX Hotel, Seoul, ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Preparing for ... p.m. – 3:00 p.m. EST, , FDA has long asserted that ... regulations apply to performing the tests and do not meet the device regulations. , ...
Breaking Medicine News(10 mins):